Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT01925131
Title S1312, Inotuzumab Ozogamicin and Combination Chemotherapy in Treating Patients With Relapsed or Refractory Acute Leukemia
Recruitment Active, not recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Southwest Oncology Group

acute lymphoblastic leukemia


Cyclophosphamide + Prednisone + Vincristine Sulfate

Inotuzumab ozogamicin

Age Groups: adult
Covered Countries USA

No variant requirements are available.